Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cultivating and Sales of Cordyceps	1.25M	1.25M	882.53K	53.30K		202.08K
Cultivating and Sales of Cordyceps Growth	-0.65%	42.03%	1555.66%	-		-
Total	1.25M	1.25M	882.53K	53.30K		202.08K
Total Growth	-0.65%	42.03%	1555.66%	-		-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
China	1.25M	1.25M	882.53K	53.30K		202.08K
China Growth	-0.65%	42.03%	1555.66%	-		-
Total	1.25M	1.25M	882.53K	53.30K		202.08K
Total Growth	-0.65%	42.03%	1555.66%	-		-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error